SpectraCure
6,4 SEK 0 %1 investor følger denne virksomhed
SpectraCure is a medical technology company The company specializes in the research and development of medical technology systems used to treat prostate cancer. The cancer treatments are based on proprietary systems that emit laser light sources and photoreactive drugs, a treatment methodology used for internally solid tumors of various types. The company operates in the Nordic market. The head office is located in Lund.
Omsætning
2,94 mio.
EBIT %
-875,17 %
P/E
-
Udbytteafkast, %
-
Kursmål
-
Anbefaling
-
Opdateret
-
First North Stockholm
SPEC
Daglig lav / høj pris
6,26 / 6,45
SEK
Markedsværdi
621,64 mio. SEK
Aktieomsætning
522,58 t SEK
Volumen
83 t
Finanskalender
Delårsrapport
17.08.2023
Delårsrapport
16.11.2023
Årsrapport
22.02.2024
Viser Alle indholdstyper